The development of relatively well-tolerated and highly active kinase inhibitors raises the question about their future role in the treatment of CLL.
Emerging role of kinase-targeted strategies in... - CLL Support
Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia ...very advanced, but may be the future....
Written by
Cllcanada
Top Poster CURE Hero
To view profiles and participate in discussions please or .
Not what you're looking for?
You may also like...
Managing the cardiovascular risk of Bruton's Tyrosine Kinase Inhibitors in chronic lymphocytic leukemia
The American Society of Hematology journal Blood Advances published an important...
Prevalence and Economic Burden of Chronic Lymphocytic Leukemia (CLL) in the Era of Oral Targeted Therapies
This has been a banner year for developments in the treatment of CLL. In this last week of 2015 on...
Advances in drug‐based therapies in chronic lymphocytic leukemia and future prospects
First published: 08 February 2019 in Advances in Cell and Gene Therapy Journal
Chronic lymphocytic...
A New Era is Coming up in the Treatment of Chronic Lymphocytic Leukemia
This is an interesting overview from Italy
The survival of patients with chronic lymphocytic...
Richter’s Transformation - Detection of early seeding of Richter transformation in chronic lymphocytic leukemia
Very interesting article on TR with Dr. Elias Campo among other doctors. Article published by the...
Related Posts
- Revolution of Chronic Lymphocytic Leukemia Therapy: the Chemo-Free Treatment Paradigm
- Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: Update on The CLARITY Study
Restoration of the immune function as a complementary strategy to treat Chronic Lymphocytic Leukemia effectively
ASH 2017: Dr. Richard Furman on the importance of MCL-1 in CLL (chronic lymphocytic leukemia)
Trabectedin Targets Leukemic Cells and Restores Immune Cell Function in Models of Chronic Lymphocytic Leukemia
